Ruth E Taylor-Piliae Selected Research

Tai Ji (Tai Chi Chuan)

1/2021	The Feasibility of Tai Chi Exercise as a Beneficial Mind-Body Intervention in a Group of Community-Dwelling Stroke Survivors with Symptoms of Depression.
1/2021	Psychometric Properties of the Translated Tai Chi Exercise Self-Efficacy Scale for Chinese Adults with Coronary Heart Disease or Risk Factors.
10/2020	Tai Chi exercise for psychological well-being among adults with cardiovascular disease: A systematic review and meta-analysis.
9/2020	Stroke Survivors' Feelings and Perceptions of Their Recovery After a Tai Chi Exercise Intervention: A Qualitative Descriptive Study.
10/2019	Tai Chi in Chinese adults with metabolic syndrome: A pilot randomized controlled trial.
12/2018	Tai Chi exercise is more effective than brisk walking in reducing cardiovascular disease risk factors among adults with hypertension: A randomised controlled trial.
1/2018	Effects of Tai Chi-based cardiac rehabilitation on aerobic endurance, psychosocial well-being, and cardiovascular risk reduction among patients with coronary heart disease: A systematic review and meta-analysis.
4/2017	The effects of Tai Chi on physical and psychosocial function among persons with multiple sclerosis: A systematic review.
4/2017	The effects of Tai Chi on physical function and well-being among persons with Parkinson's Disease: A systematic review.
5/2014	Effect of Tai Chi on physical function, fall rates and quality of life among older stroke survivors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruth E Taylor-Piliae Research Topics

Disease

9	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 03/2006
8	Stroke (Strokes) 01/2021 - 07/2007
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 12/2004
2	Hypertension (High Blood Pressure) 12/2018 - 12/2004
2	Wounds and Injuries (Trauma) 01/2017 - 12/2016
2	Chronic Disease (Chronic Diseases) 01/2004 - 03/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Overweight 12/2018
1	Multiple Sclerosis 04/2017
1	Fatigue 04/2017
1	Parkinson Disease (Parkinson's Disease) 04/2017
1	Breast Neoplasms (Breast Cancer) 11/2016
1	Lymphedema (Milroy Disease) 11/2016
1	Pain (Aches) 11/2016
1	Paresis (Hemiparesis) 01/2016
1	Ischemic Stroke 01/2016
1	Frailty 01/2016
1	Cognitive Dysfunction 01/2014
1	Dementia (Dementias) 01/2014
1	Vascular Diseases (Vascular Disease) 06/2011
1	Peripheral Arterial Disease 07/2008
1	Back Pain (Backache) 06/2003
1	Heart Diseases (Heart Disease) 03/2003
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2002

Drug/Important Bio-Agent (IBA)

2	CholesterolIBA 10/2019 - 12/2004
1	HDL CholesterolIBA 01/2019
1	mesoglycanIBA 01/2018
1	N- (2,6- dimethoxypyridine- 3- yl)- 9- methylcarbazole- 3- sulfonamideIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 03/2012
1	Nitroglycerin (Dynamite)FDA LinkGeneric 06/2011
1	Ginkgo biloba extract (Rokan)IBA 07/2008
1	Biomarkers (Surrogate Marker)IBA 09/2006

Therapy/Procedure

20	Tai Ji (Tai Chi Chuan) 01/2021 - 01/2004
2	Cardiac Rehabilitation 01/2018 - 03/2012
2	Wearable Electronic Devices 12/2016 - 01/2016
2	Therapeutics 11/2016 - 07/2008
1	Drug Therapy (Chemotherapy) 01/2021
1	Institutionalization (Institutionalized Persons) 01/2017
1	Stroke Rehabilitation 01/2016
1	Bed Rest (Bedrest) 06/2003
1	Secondary Prevention 03/2003
1	Music Therapy 10/2002